Finlan LE - Search Results

1

CK2-site phosphorylation of p53 is induced in DeltaNp63 expressing basal stem cells in UVB irradiated human skin.

Finlan LE, Nenutil R, Ibbotson SH, Vojtesek B, Hupp TR. Finlan LE, et al. Cell Cycle. 2006 Nov 1;5(21):2489-94. doi: 10.4161/cc.5.21.3393. Epub 2006 Sep 12. Cell Cycle. 2006. PMID: 17106255

2

p63: the phantom of the tumor suppressor.

Finlan LE, Hupp TR. Finlan LE, et al. Cell Cycle. 2007 May 2;6(9):1062-71. doi: 10.4161/cc.6.9.4162. Epub 2007 May 19. Cell Cycle. 2007. PMID: 17426453 Review.

3

The effect of ultraviolet (UV) A1, UVB and solar-simulated radiation on p53 activation and p21.

Beattie PE, Finlan LE, Kernohan NM, Thomson G, Hupp TR, Ibbotson SH. Beattie PE, et al. Among authors: finlan le. Br J Dermatol. 2005 May;152(5):1001-8. doi: 10.1111/j.1365-2133.2005.06557.x. Br J Dermatol. 2005. PMID: 15888160

4

Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo.

Finlan LE, Kernohan NM, Thomson G, Beattie PE, Hupp TR, Ibbotson SH. Finlan LE, et al. Br J Dermatol. 2005 Nov;153(5):1001-10. doi: 10.1111/j.1365-2133.2005.06922.x. Br J Dermatol. 2005. PMID: 16225614

5

Epidermal stem cells and cancer stem cells: insights into cancer and potential therapeutic strategies.

Finlan LE, Hupp TR. Finlan LE, et al. Eur J Cancer. 2006 Jun;42(9):1283-92. doi: 10.1016/j.ejca.2006.01.047. Epub 2006 May 6. Eur J Cancer. 2006. PMID: 16679013 Review.

6

The N-terminal interferon-binding domain (IBiD) homology domain of p300 binds to peptides with homology to the p53 transactivation domain.

Finlan L, Hupp TR. Finlan L, et al. J Biol Chem. 2004 Nov 19;279(47):49395-405. doi: 10.1074/jbc.M405974200. Epub 2004 Aug 26. J Biol Chem. 2004. PMID: 15337767 Free article.

7

Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo.

Shimizu H, Saliba D, Wallace M, Finlan L, Langridge-Smith PR, Hupp TR. Shimizu H, et al. Biochem J. 2006 Jul 15;397(2):355-67. doi: 10.1042/BJ20051521. Biochem J. 2006. PMID: 16579792 Free PMC article.

8

The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.

Ferguson M, Luciani MG, Finlan L, Rankin EM, Ibbotson S, Fersht A, Hupp TR. Ferguson M, et al. Cell Cycle. 2004 Jan;3(1):80-9. Cell Cycle. 2004. PMID: 14657672

9

DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation.

Craig AL, Holcakova J, Finlan LE, Nekulova M, Hrstka R, Gueven N, DiRenzo J, Smith G, Hupp TR, Vojtesek B. Craig AL, et al. Among authors: finlan le. Mol Cancer. 2010 Jul 21;9:195. doi: 10.1186/1476-4598-9-195. Mol Cancer. 2010. PMID: 20663147 Free PMC article.

10

Signaling to p53: the use of phospho-specific antibodies to probe for in vivo kinase activation.

Craig AL, Bray SE, Finlan LE, Kernohan NM, Hupp TR. Craig AL, et al. Among authors: finlan le. Methods Mol Biol. 2003;234:171-202. doi: 10.1385/1-59259-408-5:171. Methods Mol Biol. 2003. PMID: 12824532

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters